The present invention relates to a pharmaceutical composition for the treatment of neurological diseases including stem cells, and a method for producing the same. The pharmaceutical composition of the present invention can supply autologous stem cells which are clinically stable but can be applied to patients with neurological diseases because they do not use any animal-derived culture material unlike conventional therapeutic agents using stem cells, Can be used effectively.
展开▼
